CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 4 Shares withheld for taxes Chief Executive Officer gave up 96,999 shares (to pay taxes)
- 8-K Event Delisting notice
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Returned to the company CFO returned 49 shares (to the company)
- 4 Open-market buy Director bought 29,882 shares at an average $1.67 ($49,969)
- 3 Insider Initial Statement of Ownership
- 4 Returned to the company Director returned 7,000 shares (to the company)
- 10-Q Report Quarterly Report
- 4 Returned to the company CFO returned 49 shares (to the company)
- 4 Returned to the company CFO returned 55 shares (to the company)
- 4 Grant or award CFO acquired 430 shares (grant or award)
- 4 Returned to the company Director returned 10,000 shares (to the company)
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
Page 26 of 50 · 996 filings